Qube Research & Technologies (QRT)’s SOPHiA GENETICS SOPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.26M	Buy	+269,565	New	+$1.94M	﹤0.01%	2258

Other funds holding SOPH

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

AKRE Capital Management Middleburg, Virginia $4.42B AUM 17.77% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

AIC

AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Alta Wealth Advisors Woburn, Massachusetts $380M AUM 32.41% 1-Year Est. Return

Next Century Growth Investors Plymouth, Minnesota $1.57B AUM 96.5% 1-Year Est. Return

Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SOPH Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in SOPHiA GENETICS (SOPH) in Q3 2026: 269,565 shares worth $2.26M. The stake represents ﹤0.01% of the portfolio and ranks #2258 among its holdings.

69 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

Qube Research & Technologies (QRT) held 269,565 shares of SOPHiA GENETICS worth $2.26M as of Q3 2026.
SOPHiA GENETICS was a new Qube Research & Technologies (QRT) position in Q3 2026.
SOPHiA GENETICS made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2258 holding.
69 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.